Skip to main content
. 2009 Jun;133(6):571–581. doi: 10.1085/jgp.200910206

Figure 2.

Figure 2.

Effects of PKA on cTnI phosphorylation and Ca2+ sensitivity in PLV reconstituted with cTn or PCRF. (A; Left) SDS-PAGE for control, cTn-, and PCRF-reconstituted PLV. Cont., control with no reconstitution; cTn, cTn reconstitution; PCRF, PCRF reconstitution; Tm, tropomyosin; LC-1, myosin light chain 1; LC-2, myosin light chain 2. (B) Western blotting showing the effect of PKA on cTnI Ser23/24 phosphorylation in cTn- and PCRF-reconstituted PLV (12.5 µg protein/well). Cont., control with no treatment. Normalized intensity compared with control (n = 3): cTn, 10.12 ± 6.53%; PCRF, 13.83 ± 5.23%; cTn + PKA (PKA phosphorylation after cTn reconstitution), 214.94 ± 30.82% (P < 0.05 compared with cTn); PCRF + PKA (PKA phosphorylation after PCRF reconstitution), 228.89 ± 20.13% (P < 0.05 compared with PCRF). (C) Force-pCa curves showing the effects of cTn reconstitution and subsequent PKA treatment on Ca2+ sensitivity. (Inset) Difference between the values of the PKA-induced shift of pCa50 (C, control minus cTn + PKA; cTn, cTn minus cTn + PKA). *, P < 0.05. n = 7. (D) Force-pCa curves showing the effects of PCRF reconstitution and subsequent PKA treatment on Ca2+ sensitivity. (Inset) Difference between the values of the PKA-induced shift of pCa50 (C, control minus PCRF + PKA; PCRF, PCRF minus PCRF + PKA). *, P < 0.05. n = 7. PKA treatment did not significantly affect maximal force or nH in both C and D (see Table II).